KYPROLIS

Amgen Canada Inc🇨🇦 Health Canada

Approval Id: 77b9e84d2b1b69c4
Drug Approval Canada Name: KYPROLIS
Product Name: KYPROLIS
Status: Marketed
Status Date: 2017-02-13
Original Market Date: 2017-02-13
Din: 02459930
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01XG02 CARFILZOMIB
Atc Name: l 01 xg 02
Aig Number: 0157710002
Company Name: Amgen Canada Inc
Company Address: 300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4

CARFILZOMIB

10 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

77b9e84d2b1b69c4

Type

Standard